BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• Deals

  Zoetis To Purchase Assets Of Abbott Animal Health

  November 17, 2014

   · 

  5 min read
• BioMidwest

  Report: Medtronic, Inc. Readies $10 Billion Bond Flotation For Covidien Deal

  November 17, 2014

   · 

  1 min read
• Drug Development

  Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients

  November 17, 2014

   · 

  3 min read
• Business

  Cardiome Pharma Corp. Enters Commercialization Agreement With Aspen For BRINAVESS® In South Africa

  November 17, 2014

   · 

  5 min read
• Drug Development

  OrthoTrophix Completed Patient Treatments In Part A Of The Phase 2 Clinical Trial Of A New Cartilage Repair Therapeutic For Knee Osteoarthritis And Initiated Patient Enrollment For Part B

  November 17, 2014

   · 

  3 min read
• Pharm Country

  U.S. Department Of Defense Study Supports Favorable Benefit-Risk Profile Of Pradaxa® (dabigatran etexilate mesylate) For Reducing Stroke Risk In Non-Valvular Atrial Fibrillation

  November 17, 2014

   · 

  14 min read
• Drug Development

  AbbVie Presents Results From Study Of ABT-414 In Patients With Glioblastoma Multiforme At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology

  November 17, 2014

   · 

  5 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study

  November 17, 2014

   · 

  4 min read
• Drug Development

  Alder Biopharmaceuticals Inc. Release: Data From Phase 2b Clinical Trial Of Clazakizumab, An Anti-IL-6 Monoclonal Antibody For The Treatment Of Active Psoriatic Arthritis, To Be Presented At The American College of Rheumatology Annual Meeting

  November 17, 2014

   · 

  4 min read
• Drug Development

  Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company And Pfizer Announce Statistically Significant Results From The First Part Of The Phase 3 ANNEXA(TM)-A Studies Of Investigational Andexanet Alfa With Eliquis (Apixaban)

  November 17, 2014

   · 

  20 min read